The investment, led by Biospring Partners, will support Serán Bioscience’s expansion into commercial-scale production and state-of-the-art manufacturing facilities in Bend, Oregon.
According to the company, its commercial-scale nanoparticle manufacturing technology could reduce production costs and solvent use while increasing drug loading.
With the rise of increasingly complex biologics, innovators are leaning toward specialized service providers to bridge the gap between early breakthrough science and commercial manufacturing reality.
The Minnesota injectables CDMO has signed a technical transfer and manufacturing agreement for a currently marketed, high-viscosity injectable, marking its seventh late‑stage commercial program and 11th pipeline addition…
The European Commission has approved the ranibizumab 100 mg/mL injectable solution (Susvimo) from Roche as a treatment of neovascular age-related macular degeneration.
The newly created role will bring the CDMO’s sales, marketing, and business development teams under a unified commercial strategy across the U.S. and UK.
News
Discovery & Development
Manufacturing & Operations
Manufacturing Services
Regulatory & Compliance
